Cargando…
Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
BACKGROUND: Lung cancer is one of the leading causes of deaths from cancer worldwide. Tumor virotherapy using naturally oncolytic Newcastle disease virus (NDV) has been shown to be safe and effective in preclinical studies and clinical trials. Previously, we have reported the NDV D90 strain that was...
Autores principales: | Chai, Zheng, Zhang, Peiyi, Fu, Fang, Zhang, Xueyun, Liu, Ying, Hu, Lihua, Li, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032357/ https://www.ncbi.nlm.nih.gov/pubmed/24885546 http://dx.doi.org/10.1186/1743-422X-11-84 |
Ejemplares similares
-
A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
por: Huang, Feng-Ying, et al.
Publicado: (2020) -
Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015) -
Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
por: Numpadit, Supaporn, et al.
Publicado: (2023) -
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
por: Jiang, Ke, et al.
Publicado: (2018) -
Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
por: Harper, James, et al.
Publicado: (2021)